Filing Details

Accession Number:
0001209191-19-052177
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-03 16:25:24
Reporting Period:
2019-10-01
Accepted Time:
2019-10-03 16:25:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1789815 Ourania Tatsis 50 Northern Avenue
Boston MA 02210
Svp, Cro No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-10-01 188 $169.11 7,696 No 4 S Direct
Common Stock Disposition 2019-10-02 444 $167.69 7,252 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1.